1. FRI0231 Treatment with BI 655064 (Antagonistic Anti-CD40 Antibody) Modulates Biomarkers Associated with Rheumatoid Arthritis (RA). (15th July 2016) Authors: Visvanathan, S.; Ramanujam, M.; Schoelch, C.; Vinisko, R.; Mueller-Ladner, U.; Padula, S.; Fine, J.S.; Steffgen, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0128 Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of BI 638683, A Novel CCR1 Antagonist. (10th June 2014) Authors: Baum, P.; Schoelch, C.; Zimdahl-Gelling, H.; Brown, M.; Webb, D.; Padula, S.; Hilbert, J.; Giessmann, T.; Steffgen, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗